帕金森病中阿波莫尔芬输液的实际使用:TOLEDO研究的教训和临床经验
Tove Henriksen1, Regina Katzenschlager2, Roongroj Bhidayasiri3,4
1Department of Neurology, Movement Disorder Clinic, University Hospital of Bispebjerg, 2400, Copenhagen, Denmark. tovehenriksen@dadlnet.dk.
Journal of neural transmission (Vienna, Austria : 1996)
|September 1, 2023
概括
皮下阿波莫尔芬输注为帕金森病患者提供了一种不那么侵入性的治疗选择,这些患者经历了持续的运动波动. 成功治疗需要患者一致性和专注的临床支持,特别是在初始治疗阶段.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 管理通常涉及解决对口服/透皮治疗无反应的持续运动波动.
- 当传统治疗方法变得不足时,设备辅助疗法被考虑.
研究的目的:
- 为在帕金森病患者中启动和管理皮下阿波莫尔芬输注提供实用指南.
- 提供基于临床试验数据和现实世界专家经验的见解.
主要方法:
- 对TOLEDO随机临床试验数据的后期分析.
- 一个基于问卷的对13名运动障碍专家"现实世界"经验的分析.
主要成果:
- 皮下阿波莫尔芬输液是一种可行的,不那么侵入性的替代方法,可以替代其他先进的疗法,如大脑深度刺激.
- 考虑到医疗保健的差异,制定了启动阿波莫尔芬输注的指导方针.
- 治疗的成功取决于患者/家庭一致性和经验丰富的临床支持.
结论:
- 皮下阿波莫尔芬输液是晚期帕金森病的实用治疗选择.
- 有效实施需要多学科的方法和患者的参与.
- 本指南支持医疗保健专业人员优化阿波莫芬输液治疗.
相关概念视频
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Parkinson's Disease: Overview
593
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
593
Direct-Acting Cholinergic Agonists: Therapeutic Uses
790
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
790
Cholinergic Antagonists: Therapeutic Uses
775
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
775
Drug Delivery: Parenteral Route
608
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
608
Adrenergic Agonists: Therapeutic Uses
840
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
840


